We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTRPA
976
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$111K ﹤0.01%
+146,419
New +$188K
SGU icon
977
Star Group
SGU
$411M
$109K ﹤0.01%
+11,932
New +$123K
WNEB icon
978
Western New England Bancorp
WNEB
$281M
$108K ﹤0.01%
14,419
-13,014
-47% -$108K
AVYA
979
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$108K ﹤0.01%
+48,287
New +$345K
BCEL
980
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$97K ﹤0.01%
54,301
-27,450
-34% -$57.4K
CRD.B icon
981
Crawford & Co Class B
CRD.B
$583M
$96K ﹤0.01%
13,606
-133
-1% -$973
PASG icon
982
Passage Bio
PASG
$15.2M
$95K ﹤0.01%
2,016
-299
-13% -$14K
ORIC icon
983
Oric Pharmaceuticals
ORIC
$1.43B
$94K ﹤0.01%
+21,063
New +$84K
GTYH
984
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$94K ﹤0.01%
15,092
-30,526
-67% -$156K
EIGR
985
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$91K ﹤0.01%
479
-293
-38% -$59.1K
DBD
986
DELISTED
Diebold Nixdorf Incorporated
DBD
$91K ﹤0.01%
+40,293
New +$150K
APYX icon
987
Apyx Medical
APYX
$124M
$90K ﹤0.01%
+15,396
New +$79K
TUSK icon
988
Mammoth Energy Services
TUSK
$163M
$88K ﹤0.01%
40,193
+15,385
+62% +$34.5K
YRD
989
Yiren Digital
YRD
$104M
$86K ﹤0.01%
47,575
-8,618
-15% -$16.6K
ZYME icon
990
Zymeworks
ZYME
$1.83B
$86K ﹤0.01%
+16,287
New +$98.5K
PSNL icon
991
Personalis
PSNL
$1.53B
$85K ﹤0.01%
+24,669
New +$126K
AVAL icon
992
Grupo Aval
AVAL
$6.43B
$84K ﹤0.01%
23,567
-114,057
-83% -$474K
SIRI icon
993
SiriusXM
SIRI
$9.45B
$84K ﹤0.01%
1,371
-319
-19% -$19.8K
MUX icon
994
McEwen Inc
MUX
$1.14B
$83K ﹤0.01%
19,857
-16,725
-46% -$104K
AKBA icon
995
Akebia Therapeutics
AKBA
$240M
$80K ﹤0.01%
226,770
-244,911
-52% -$103K
GSIT icon
996
GSI Technology
GSIT
$260M
$80K ﹤0.01%
23,152
+92
+0.4% +$331
BBCP icon
997
Concrete Pumping Holdings
BBCP
$479M
$79K ﹤0.01%
+13,094
New +$74.3K
OVID icon
998
Ovid Therapeutics
OVID
$513M
$79K ﹤0.01%
36,748
-50,140
-58% -$121K
STKL
999
DELISTED
SunOpta
STKL
$79K ﹤0.01%
+10,200
New +$67.2K
CLSD
1000
DELISTED
Clearside Biomedical
CLSD
$74K ﹤0.01%
3,335
-1,948
-37% -$47.3K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.